IRITH WEISSMAN, M.D.; NORBERTO KRIVOY, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: We report the cases of three patients on chronic hemodialysis treated concomitantly by aluminum hydroxide and allopurinol for high uric acid and phosphate concentration. Initially the uric acid blood concentration did not change; allopurinol was then given 3 hours before the aluminum hydroxide, and there was a decrease in uric acid concentration.
A 21-year-old woman receiving hemodialysis was given allopurinol, 300 mg/d, concomitantly with aluminum hydroxide, 5.7 g/d. After 1 month of combined therapy the uric acid concentration was 25.7 mg/dL. She was advised to allow 3 hours between the aluminum hydroxide and allopurinol. One month later
WEISSMAN I, KRIVOY N. Interaction of Aluminum Hydroxide and Allopurinol in Patients on Chronic Hemodialysis. Ann Intern Med. 1987;107:787. doi: https://doi.org/10.7326/0003-4819-107-5-787_1
Download citation file:
Published: Ann Intern Med. 1987;107(5):787.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use